In contrast, one study suggested that Cnt supplementation (50 μM) in HCT 116 cells increases butyrate oxidation, promoting cancer cell survival by reducing its epigenetic impact and potentially limiting its role as an HDAC inhibitor while reducing histone acetylation [60]. This evidence concerns the gene HDAC9 and cancer.